What a Data-Sovereignty-First Care Brand Should Budget to Acquire a Patient

The question

"What's a realistic patient-side acquisition cost for a data-sovereignty-first care brand?" Surfaced as an open follow-up from the 2026-05-10 healthcare outcome-procurement brief (Michael Holzum origin), which flagged "no analog; closest is Iora/One Medical at ~$300-500 CAC for a Medicare panel." This feeds the active patient-data-sovereignty healthcare bet's unit economics.

What we already know (from the vault)

• [[2026-05-10-healthcare-outcome-procurement-pioneering-provider]] is the origin: it explicitly conceded "no analog" for a data-sovereignty-first care brand and used ~$300-500 CAC (Iora/One Medical, Medicare panel) as the placeholder. The same brief prices the ACCESS Model onboarding economics at ~$10 onboarding + $30/review ($100/beneficiary/year floor) — a payer-channel number, not a marketing CAC.
• [[2026-05-11-marchione-primary-care]] is the sharpest contradicting evidence in the vault: Max Marchione reports DTC direct-primary-care membership CACs "exceeding $2,000" against a $199-500/yr price point (multi-year payback), cites One Medical down 85% pre-Amazon and Teladoc down 90%, and argues the killer is distribution, not clinical model. Parsley Health's fix was employer-reimbursement (aligned-payer channel), not paid DTC.
• [[2026-05-11-patient-data-sovereignty-competitor-scan]] gives the closest true analog: PicnicHealth-style consented-cohort recruitment runs ~$200-500 per consented patient per condition. It also notes the bet is B2B2C through ACO panel attribution — "panel-attribution does the choosing" — so patient-side CAC may be structurally lower than any DTC number.
• [[2026-05-10-data-sovereignty-outcome-procurement-bet-architecture]]: the recommended Phase-1 path (Variant A/C) sells into VBC operators or orchestrates a panel, i.e. it does NOT rely on DTC membership marketing. Variant B operator economics are ~$50-150 PMPM cost against $100-300 PMPM revenue. Only Variant D (coop) is genuinely DTC.

What the web says

• Generic primary-care digital acquisition clusters at $150-400/patient: First Page Sage (2024 data, 2021-25) shows General Practice $203, Family Practice $277, Pediatrics $155 PAC (firstpagesage.com); brighterclick's 2026 benchmark puts primary care at $75-350 (brighterclick.com).
• DTC telehealth/digital-health runs higher — $150-500/patient — and high-consideration categories run far higher: behavioral health $500-2,500+, clinical-trial recruitment $500-2,500 (brighterclick.com). A novel data-sovereignty brand behaves like a high-consideration category.
• Medicare Advantage panel acquisition is expensive: ~$800-1,000 per member, against ARPU ~$10k and a 3-5 year member lifetime (medium.com/@abhasvc). This is meaningfully above the $300-500 the origin brief attributed to Iora.
• "True" PAC is 4-6x the reported cost-per-lead: a $50 lead at a 20% show rate is a $250 real PAC — most orgs understate CAC by measuring form-fills (brighterclick.com).
• Category-wide headwind: blended CAC is up ~60% over five years (privacy regulation, ad-cost inflation, competition); healthy benchmark is LTV:CAC ~3:1 and payback under 12 months (userpilot.com). An $85/member DPC target circulates in model templates but reads as aspirational, not empirical.

Convergences and contradictions

• The $300-500 comp only half-holds. It is a defensible midpoint for generic DTC digital primary care (converges with First Page Sage $203-277 and brighterclick $75-350 on the low end, $500 telehealth on the high end). But it is optimistic-to-wrong for the two shapes that actually matter: real DPC/membership CAC is >$2,000 (vault/Marchione), and Medicare Advantage panel CAC is ~$800-1,000 (web). The origin brief anchored to the friendliest number.
• Both sources agree the acquisition model dominates the number. Marchione (vault) says distribution is the whole game; the competitor scan (vault) says panel-attribution does the choosing; the web confirms DTC paid acquisition is inflating ~60% over five years. The consistent signal: whoever pays for the channel determines the CAC, and DTC is the expensive path.

Synthesis for RDCO

The honest answer is that "patient-side CAC" is bimodal, and the bet's own architecture already picks the cheap mode. If RDCO runs the recommended Variant A/C path — selling the measurement-and-payout layer into VBC operators, or orchestrating an ACO-attributed panel — then patient-side CAC is not the binding constraint. The panel arrives with the payer contract; the real cost is BD/contracting amortized across the panel plus a per-member onboarding-and-consent cost in the ~$50-200/member range (consistent with the origin brief's ~$10 onboarding + ~$30/review ACCESS economics and PicnicHealth-style consent flows). In this mode the $300-500 comp overstates the direct patient CAC because there is no DTC membership funnel to pay for.

If the bet ever runs genuinely DTC — a paid membership brand (Variant D coop, or a direct consumer front door) — plan for $300-800 blended, with a real risk of $1,000-2,000 in a paid-digital-heavy mix. A data-sovereignty-first brand is a novel category: it carries the same high-consideration education tax as behavioral health ($500-2,500) and clinical-trial recruitment ($500-2,500), because the patient has to be taught a new mental model ("you own your data AND get paid from the savings") before converting. That education tax pushes CAC up relative to generic primary care. Working the other direction, the patient-payout hook is a genuinely differentiated acquisition lever — a tangible cash incentive, not just "better care" — which is exactly the distribution-channel innovation Marchione says is missing. If the savings-share is real, provable, and marketable, it can pull effective DTC CAC toward the $300-500 floor rather than the $2,000 ceiling. That is the single most testable lever in the whole model.

So the defensible planning ranges: payer-attributed / B2B2C: $50-200 per member (the mode the bet should default to); DTC digital primary-care shape: $300-800; DTC paid-membership shape: budget $800 and stress-test to $2,000. The $300-500 Iora/One Medical comp should be retired as the headline number — it is neither the cheap-mode reality (~$100) nor the expensive-mode reality (>$2,000), it is a blended midpoint for a channel the bet is deliberately trying not to use. For unit-economics sizing against the origin brief's ~$100/beneficiary/year OAP floor and $100-300 PMPM revenue, a payer-attributed CAC of $50-200 keeps LTV:CAC comfortably above 3:1 on a 3-5 year member life; a DTC CAC above ~$800 breaks the model unless the patient-payout lever is proven to compress it.

Open follow-ups

• What is the empirical CAC for a payer-attributed ACO panel specifically — i.e. the fully-loaded BD-plus-onboarding cost per attributed beneficiary, not the DTC marketing number? (Requires an operator conversation; Aledade/Strive-shape benchmark.)
• Does the patient-payout ("get paid from the savings") hook measurably lower CAC vs a care-quality pitch? This is the highest-leverage A/B test in the model and currently unmeasured.
• What did One Medical's actual blended CAC look like at the point Amazon acquired it (the vault only has "down 85%")? A real number would calibrate the DTC ceiling.
• What is Discovery Vitality's member-acquisition cost, given its payout-for-behavior model is the closest live analog to the incentive-alignment thesis?
• How much of the ~60% five-year CAC inflation is privacy-regulation-driven — and does a data-sovereignty-first brand get a lower effective CAC because privacy is its native positioning rather than a compliance cost?

Related

• [[2026-05-10-healthcare-outcome-procurement-pioneering-provider]]
• [[2026-05-10-data-sovereignty-outcome-procurement-bet-architecture]]
• [[2026-05-11-patient-data-sovereignty-competitor-scan]]
• [[2026-05-11-marchione-primary-care]]
• [[2026-06-02-mostly-metrics-fanatics-ltv-cac-product-lines]]

Sources

Vault:

• ~/rdco-vault/06-reference/research/2026-05-10-healthcare-outcome-procurement-pioneering-provider.md
• ~/rdco-vault/01-projects/health-and-longevity/2026-05-10-data-sovereignty-outcome-procurement-bet-architecture.md
• ~/rdco-vault/06-reference/research/2026-05-11-patient-data-sovereignty-competitor-scan.md
• ~/rdco-vault/01-projects/health-and-longevity/2026-05-11-marchione-primary-care.md

Web (accessed 2026-07-06):

• First Page Sage, "Average Patient Acquisition Cost: 2026 Report" — https://firstpagesage.com/seo-blog/average-patient-acquisition-cost/
• BrighterClick, "Healthcare Patient Acquisition Cost in 2026: CAC Benchmarks by Specialty" — https://www.brighterclick.com/blog-post/healthcare-marketing-trends
• Abhas Gupta, MD, "The Medicare Advantage Startups: Unicorns or Donkeys?" (Medium) — https://medium.com/@abhasvc/the-medicare-advantage-startups-unicorns-or-donkeys-a8acf3881ee5
• Userpilot, "Average Customer Acquisition Cost (CAC) Industry Benchmarks (2026)" — https://userpilot.com/blog/average-customer-acquisition-cost/